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Abstract
The influence of surface charge of nanomaterials on toxicological effects is not yet fully understood. 
We investigated the inflammatory response, the acute phase response and the genotoxic effect of 
two different titanium dioxide nanoparticles (TiO2 NPs) following a single intratracheal instillation. 
NRCWE-001 was unmodified rutile TiO2 with endogenous negative surface charge, whereas 
NRCWE-002 was surface modified to be positively charged. C57BL/6J BomTac mice received 18, 
54 and 162 µg/mouse and were humanely killed 1, 3 and 28 days post-exposure. Vehicle controls 
were tested alongside for comparison. The cellular composition and protein concentration were 
determined in bronchoalveolar lavage (BAL) fluid as markers for an inflammatory response. 
Pulmonary and systemic genotoxicity was analysed by the alkaline comet assay as DNA strand 
breaks in BAL cells, lung and liver tissue. The pulmonary and hepatic acute phase response was 
analysed by Saa3 mRNA levels in lung tissue or Saa1 mRNA levels in liver tissue by real-time 
quantitative polymerase chain reaction. Instillation of NRCWE-001 and -002 both induced a dose-
dependent neutrophil influx into the lung lining fluid and Saa3 mRNA levels in lung tissue at 
all assessed time points. There was no statistically significant difference between NRCWE-001 
and NRCWE-002. Exposure to both TiO2 NPs induced increased levels of DNA strand breaks in 
lung tissue at all doses 1 and 28  days post-exposure and NRCWE-002 at the low and middle 
dose 3 days post-exposure. The DNA strand break levels were statistically significantly different 
for NRCWE-001 and -002 for liver and for BAL cells, but no consistent pattern was observed. In 
conclusion, functionalisation of reactive negatively charged rutile TiO2 to positively charged did not 
consistently influence pulmonary toxicity of the studied TiO2 NPs.
Introduction
Titanium dioxide (TiO2) is one of the most commonly produced 
and widely used nanoparticles (NPs). The nanosized form has a 
wide range of uses such as an ultraviolet (UV) filter in cosmet-
ics and lacquers, and aggregated or agglomerated nanosized and 
micronsized forms are the most commonly used white pigment 
in paints, paper, plastics, toothpaste, pharmaceuticals, candy and 
food. TiO2 particles are considered insoluble and chemically stable, 
but as the particle size is reduced, they become more reactive (1–3) 
and they are also used as for catalysts, especially in combination 
with UV light.
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Inhalation of nanosized TiO2 particles may potentially cause 
adverse health effects in exposed workers and consumers (4). TiO2 is 
classified by the International Agency for Research on Cancer (IARC) 
as being possible carcinogen to humans by inhalation (Group 2B), 
based on sufficient evidence in experimental animals and inadequate 
(little) evidence from epidemiological studies (5), and the European 
Chemicals Agency recently opened for commenting a proposition 
for classifying TiO2 as a carcinogen (Carc 1B) in Europe (available 
at: https://www.paint.org/echa-releases-french-dossier-titanium-
dioxide-public-comment/). There is, however, no conclusive evidence 
of TiO2-related cancer after the occupational exposure (6,7), and it 
has been proposed that it is carcinogenic only after massive pro-
longed inhalation exposure. The National Institute for Occupational 
Safety and Health (NIOSH) has proposed an occupational exposure 
limit of 0.3 mg/m3 for ultrafine TiO2 particles (8), compared with 
the current occupational exposure limit of 10 mg/m3 TiO2 or 6 mg/
m3 titanium (Ti) in Denmark (available at: http://arbejdstilsynet.dk/
da/regler/at-vejledninger/g/c-0-1-graensevaerdi-for-stoffer-og-mat).
Inhaled NPs deposit in the deep respiratory tract and have been 
shown to remain in the lung for long times (9–12). In the occupational 
settings, lung is a primary target organ of NP exposure. Airway expo-
sure (inhalation as well as pulmonary instillation) to TiO2 NPs has 
been reported to cause inflammation, pulmonary damage, plaque pro-
gression and DNA damage in rodents (1–3,10,13–18). Intratracheally 
instilled TiO2 NPs are engulfed by pulmonary macrophages, translo-
cate at a low rate and accumulate primarily in the liver, but also in 
other organs such as heart, kidney, placenta and brain (9–11,19,20). 
The translocation is very limited and represents less than 1% of the 
initial pulmonary burden at 1 week post exposure (19). The toxicol-
ogy of TiO2 NPs exposure was recently reviewed by Shi et al. (21).
To facilitate hazard assessment of nanomaterials (NMs), it is 
important to identify the physico-chemical properties of NMs that 
predict adverse outcomes. The total surface area of deposited NPs 
seems to be an important predictor of pulmonary inflammation and 
acute phase response (3,22–24). The role of surface modification and 
surface charge is less clear (3).
The purpose of this study was to compare the inflammatory and 
genotoxic effects of two types of TiO2 NPs with different surface 
charge after intratracheal instillation (i.t.) in mice. The adverse effects 
were determined 1, 3 and 28 days post-exposure. The chosen doses 
correspond to the estimated pulmonary deposition during 1.5, 5 and 
15 working days at the current Danish occupational exposure level 
for TiO2 (10 mg/m
3) assuming 9% alveolar deposition and a ventila-
tion rate of 1.8 l/h (9,14). Inflammation was determined as the influx 
of inflammatory cells in the lung lining fluid [by the cellular composi-
tion in the bronchoalveolar lavage (BAL) fluid (BALF)], and BALF 
protein concentration was assessed as a general marker of lung tis-
sue damage. Saa3 mRNA levels in lung and Saa1 levels in liver were 
used as biomarkers for acute phase response (24–26). Genotoxicity 
was assessed as DNA strand breaks determined by comet assay in 
BAL cells, lung and liver. The biological markers and time points were 
chosen to enable comparison of adverse health effect with other NPs 
tested in our lab with the same set-up and increase knowledge of pre-
diction the adverse effects of other NMs (2,10,15,17,25–31).
Materials and methods
Mice
Female mice C57BL/6J BomTac aged 6–7 weeks were obtained 
from Taconic Europe (Ejby, Denmark). Mice were allocated ran-
domly to the experimental groups and were acclimatized for 1–2 
weeks before the start of experiment. The caging conditions were as 
previously described in detail (32). Briefly, all mice were housed in 
polypropylene cages with bedding (sawdust) and activity enrichment 
at controlled environmental conditions; temperature (21 ± 1°C), 
humidity (50 ± 10%) and 12 h light/dark period. Mice had access to 
food (Altromin 1324) and tap water ad libitum. The animals were 
assigned to i.t. at 8 weeks of age. The average weight at the day 
of instillation was 18.5 ± 1.3 g. All procedures complied with the 
EC Directive 86/609/EEC and Danish law regulating experiments 
with animals (The Danish Ministry of Justice, Animal Experiments 
Inspectorate, permission 2010/561–1779).
Study design
Mice were intratracheally instilled with a single dose of vehicle 
(Nanopure water), and two different TiO2 NPs NRCWE-001 and 
NRCWE-002 in doses: 18, 54 or 162 µg/mouse, mice were killed after 
1, 3 or 28 days. The chosen doses correspond to 1.5, 5 and 15 working 
days at the Danish occupational exposure level for TiO2 (6.0 mg Ti/
m3–10 mg TiO2/m
3), respectively. NPs groups consisted of 8 mice for 
each dose and time point, and the vehicle control group consisted of 
12 mice for each time point. The organs and BAL were collected 1, 3 
and 28 days post-exposure. A total of 180 mice were used in this study. 
Data on the vehicle controls have been published previously (30).
Particle characterisation and preparation of exposure  
stock
In this study, two rutile TiO2 NPs (NRCWE-001 and NRCWE-002) 
were used. NRCWE-001 particle was purchased from NanoAmor 
(Houston, TX, USA) and used for production of NRCWE-
00NRCWE-002 (positively charged; amino-TiO2) at the National 
Research Center for Working Environment (33). The NRCWE-002 
was surface functionalised by 3-aminopropyltriethoxysilane (purity 
99%, Sigma-Aldrich, Glostrup, Denamark). The zeta potential of 
NRCWE-001 was −36.8 mV at pH 7.22, −26 mV at pH 7.0 and −7.2 
mV at pH 4.4 and for NRCWE-002 was 35.4 mV at pH 7.4, 25 mV 
at pH 7.0 and 20.4 mV at pH 4.4 (all in about 1 mM sodium phos-
phate buffer). A detailed description of the preparation was reported 
previously (34). Both particles have 10 nm declared primary parti-
cle sizes, the Brunauer–Emmett–Teller (BET) analysis (BET) surface 
area for NRCWE-001 is 99 m2/g and 84 m2/g for NRCWE-002, 
respectively (3,34).
NPs were suspended in 0.2 µm filtered, γ-irradiated Nanopure 
Diamond UV water (Pyrogens: ˂0.001 EU/ml, total organic carbon: 
˂3.0 ppb) and sonicated on ice, for 16 min without pause, using a 
Branson Sonifier S-450D (Branson Ultrasonics Corp., Danbury, CT, 
USA) equipped with a disruptor horn (model number 101-147-037). 
The desired concentrations were 18, 54 and 162  µg/instillation. 
The 3.24 mg/ml (162  µg/instillation) suspension was subsequently 
diluted 1:3 to obtain 1.08 mg/ml (54 µg/instillation) and diluted fur-
ther 1:3 for the lowest dose 0.36 mg/ml (18  µg/instillation). Each 
of these dilutions were sonicated for extra 2 min before instillation. 
Vehicle was prepared by sonication of Nanopure Diamond water 
in the same conditions and duration (16 min) as described above. 
All suspensions were freshly made for the instillation and were only 
used for up to 1 h post preparation.
Dynamic light scattering
The hydrodynamic size distributions in suspensions were determined 
by dynamic light scattering (DLS) using Malvern Zetasizer Nano ZS 
(Malvern Instruments Ltd, UK). Data were analysed on Dispersion 
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Technology Software v5.0 (Malvern Instruments Ltd). The size dis-
tribution was determined directly after sonication on the instillation 
dispersions at 25°C in 1 ml disposable polystyrene cuvettes. All data 
were obtained based on six consecutively repeated analyses of the 
same sample with no pause. For calculation of hydrodynamic size, 
we used the refractive (Ri) and absorption indices (Rs) of 2.903 and 
0.10, respectively, for both rutile TiO2 NPs and standard optical and 
viscosity properties for H2O.
Particle exposure by i.t.
Eight-week-old female mice were once instilled intratracheally under 
isofluorane sedation as previously described (35). Briefly, mice were 
anaesthetized with 4% isofluorane and instilled through the tra-
chea with vehicle or TiO2 NPs dispersed in vehicle (50 µl solution 
followed by 200 µl air). The total instilled doses were 18, 54 and 
162 µg/mouse. After instillation, the mice were weighed and trans-
ferred to the home cage until termination.
BAL preparation and isolation of organs
Upon termination, mice were anaesthetized using Hypnorm® (fen-
tanyl citrate 0.315 mg/ml and fluanisone 10 mg/ml from Janssen 
Pharma) and Dormicum® (Midazolam 5 mg/mL from Roche). Both 
anaesthetics were mixed with equal volumes of sterile water. Heart 
blood was withdrawn. Lungs were flushed twice with sterile 0.9% 
sodium chloride (NaCl) through the trachea to obtain BALF. The 
volume used for each flush was calculated as 1 ml 0.9% NaCl/25 g 
mouse weight and varied from 0.7 to 0.9 ml. The BALF was stored 
on ice until centrifugation at 400 × g for 10 min at 4°C. Acellular 
BALF was recovered and stored at −80°C. The BAL cells were resus-
pended in 100 µl medium (HAM F-12 with 1% penicillin/streptomy-
cin and 10% fetal bovine serum).
The total number of living and dead cells in BAL was determined 
by NucleoCounter NC-200TM (Chemometec, Denmark) from 20 µl 
diluted cell suspension following manufacturer’s protocol. Samples 
for COMET assay were prepared from 40 µl resuspended BAL cells 
and 60 µl freezing media (HAM F-12, 1% penicillin/streptomycin, 
15% fetal bovine serum and 10% dimethyl sulphoxide). Samples 
were divided into two aliquots of 50 µl each and immediately frozen 
at −80°C. The rest of cell resuspension (40 µl) was used to determine 
cell composition. The cell suspension was centrifuged at 55 × g for 
4 min in Cytofuge 2 (StatSpin, TRIOLAB, Brøndby, Denmark) on to 
a microscope glass slide and then fixed for 5 min in 96% ethanol. All 
slides were stained with May-Grünwald-Giemsa, randomised and 
blinded, before counting 200 cells/sample under light microscope 
(100× magnification, immersion oil). Lung and liver tissues were 
divided into four parts, snap frozen in liquid nitrogen, and stored 
at −80°C.
Comet assay: preparation and analyses
DNA strand breaks were determined on frozen BAL cells suspen-
sion, lung (3 × 3 mm of left lobe) and liver tissue (3 × 3 mm piece 
of the median lobe). Sample preparation and comet analysis has 
previously been described in detail (36). Briefly, BAL cells, lung or 
liver cell suspensions, were embedded in agarose (0.7% final con-
centration) on Trevigen 20-Well CometSlides™. Slides were quickly 
immersed into lysing solution at 4°C and stored overnight. On 
the next day, samples were alkaline treated and subjected to alka-
line electrophoresis in ice-cold circulating electrophoresis solution 
(25 min, 1.15 V/cm, pH ˃13). Samples were neutralised, fixed and 
later stained by SYBRGreen®. Comets were scored by the fully 
automated PathFinder™ system (IMSTAR, France). DNA strand 
breaks were quantified as %DNA in the comet tail (%TDNA) and 
the comet tail length (TL). The day-to-day variation and electro-
phoresis efficiency was controlled by including phosphate-buffered 
saline exposed and 60 µM hydrogen peroxide-exposed A549 cells 
as negative and positive controls, respectively, on all comet slides. 
Control cells were exposed for 30 min at 4°C as described (36). The 
day-to-day variation for the comet assay analysis on BAL, lung and 
liver tissue (n = 19 for each tissue) were 19.3%, 13.1% and 16.7%, 
for TL, respectively.
Total protein concentration in BALF
Total protein content in BALF was measured by Pierce®BCA Protein 
Assay Kit (Thermo Scientific, USA) according to the manufacturer’s 
protocol. Briefly, protein concentration of all unknown acellular 
BALF samples were compared to a standard curve of known albu-
min concentrations. Samples were prepared in duplicates and were 
incubated 30 min in 37°C. Absorbance was measured at 550 nm on 
Victor Wallac 1420 Multilabel counter (Turku, Finland).
Saa mRNA expression analysis
RNA from right lung (16–20 mg) and liver (a sample of 15–25 mg) 
was isolated using Maxwell® 16 LEV simply RNA Tissue Kit 
(AS1280, Promega, USA) according to the manufacturer’s proto-
col. RNA was eluted by 50  µl nuclease-free (DEPC) water. cDNA 
was prepared from DNAse-treated RNA using Taq-Man® reverse 
transcription reagents (Applied Biosystems, USA) as described by 
manufacturer’s protocol. Total RNA and cDNA concentration was 
measured on NanoDrop 2000c (ThermoFisher, USA). The Saa3 and 
Saa1 gene expression was determined using real-time reverse tran-
sciptase polymerase chain reaction (RT-PCR) with 18S RNA as refer-
ence gene as previously described (23,37). In brief, each sample was 
run in triplicates on the ViiA7 Real-Time PCR (Applied Biosystems, 
USA). In all assays, TaqMan predeveloped master mix (Applied 
Biosystems, USA) was used. Target and 18S RNA levels were quan-
tified in triplicates in separate wells. The relative expression of the 
target gene was calculated by the comparative method 2 t-∅C . mRNA 
measurements were excluded if the 18S RNA content fell outside the 
linear range in which the PCR was found to be quantitative defined 
by the validation experiments. Negative controls, where RNA had 
not been converted to cDNA (no template control), were included 
in each run. A  plate control was included in all real-rime RT-PCR 
analyses. The sequences of the Saa3 primers and probe were: Saa3-
forward: 5ʹ GCC TGG GCT GCT AAA GTC AT 3ʹ, Saa3-reverse: 
5ʹ TGC TCC ATG TCC CGT GAA C 3ʹ and Saa3-probe: 5ʹ FAM-
TCT GAA CAG CCT CTC TGG CAT CGC T-TAMRA 3ʹ.The day-
to-day variation for the plate control in the Saa3 analyses was 9.9 
%. For Saa1 expression analyses, a primer/probe mix was used (Assay 
ID: Mm00656927_g1, ThermoFisher Scientific, USA). The day-to-day 
variation for the plate control in the Saa1 analyses was 11.9%.
Statistical analyses
The experimental data were transformed by logarithmic transforma-
tion (comet assay, protein concentration and Saa3 and Saa1 mRNA 
level) or ranked (BAL cell composition) and analysed by two-way 
analysis of variance (ANOVA). If statistical significance was reached 
in the overall ANOVA test (dose and time were used as categori-
cal parameters), a post hoc Tukey-type multiple comparison test 
was used. If the interaction was significant, one-way ANOVA was 
performed with post hoc Tukey-type multiple comparison test. 
The relevant particle differences were tested by one-way ANOVA, 
where surface modification was used as categorical value. Statistical 
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significances were tested at P  <  0.05 level. All data in the article 
and tables are expressed as mean ± SEM. The statistical analyses 
were performed in MiniTab®15.1.0.0 (MiniTab Inc., UK), with the 
exception of Saa1 expression analyses, which were performed in SAS 
version 9.3 (SAS Institute Inc., Cary, NC, USA).
Results
Particle characterisation
All NPs were dispersed in Nanopure water. Size distributions were 
measured by DLS and are summarized in the Table 1. Unmodified 
nanoparticle NRCWE-001 shows identical properties at all concen-
trations. Agglomerates were smaller than 100 nm, at all concentra-
tions; the final suspensions appeared dispersed, stable and we did 
not observe large aggregates. The positively charged NRCWE-002 
formed larger agglomerates, and the agglomerate size varied between 
1281 nm (0.36 mg/ml) and 1718 nm (3.24 mg/ml; Figure 1).
Mouse weight
Mice exposed to NRCWE-001 had a weight gain similar to vehicle 
controls. Body weight of the NRCWE 002-exposed mice was unaf-
fected by instillation 1 and 3  days post-exposure. Mice had dose 
dependently lower weight gain 28 days after exposure to NRCWE-
002 compared with vehicle-exposed mice (P  <  0.001; data not 
shown).
BALF cell composition
Recruitment of inflammatory cells in BALF was assessed as a marker 
of pulmonary inflammation (Table 2).
The total number of cells in BALF was statistically significantly 
increased 1 and 3 days post-exposure for both TiO2 NPs compared 
with the vehicle control (P  <  0.001) and at day 28 for NRCWE-
001. There was no statistically significant difference in total BAL cell 
numbers between the two TiO2 NPs.
For both TiO2 NPs, dose-dependent neutrophil influx was 
observed 1 day, 3 days and 28 days post-exposure. Exposure to the 
lowest dose of 18 µg TiO2 NPs did not affect neutrophil recruitment 
into lung at any studied time point.
The number of macrophages in BALF was statistically signifi-
cantly decreased 1  day following exposure to the highest dose of 
NRCWE-001. The number of macrophages increased over time 
after instillation and at day 28, the number of macrophages was 
increased 2.1-fold compared with vehicle controls for the highest 
dose (P < 0.001) for NRCWE-001. The number of macrophages in 
BAL compared with vehicle controls was unaffected by i.t. exposure 
to NRCWE-002 at all doses. At post-exposure Day 3, a statistically 
significantly increased number of eosinophils was observed after 
exposure to the highest dose of both TiO2 NPs and the middle dose 
of NRCWE-002. The number of lymphocytes was increased for the 
middle and highest dose 28 days post-exposure NRCWE-002 com-
pared with vehicle controls.
The inflammatory response was dose dependent, and we did not 
observe any statistically significant differences between NRCWE-
001 and NRCWE-002.
Successful delivery of TiO2 NP to the lung was confirmed by 
the presence of particles in BALF from all exposed mice (results 
not shown). TiO2 NPs were observed outside as well as inside 
macrophages. The number of free as well as engulfed particles 
decreased in time, but both TiO2 NPs were still observed 28 days 
post-exposure (results not shown) as previously reported for other 
NPs (10,30).
DNA strand breaks
Genotoxicity was evaluated as alkali-labile sites and DNA strand 
breaks by the comet assay in BAL cells, lung and liver tissue (Table 3; 
Figure 2).
Overall, significantly increased levels of DNA strand breaks 
assessed as TL were observed in the lung tissue 1 day after expo-
sure to all NRCWE-001 and all NRCWE-002 doses (Figure 2). DNA 
strand break levels expressed as %TDNA were only statistically 
significantly increased for the dose 54 µg NRCWE-002 (P < 0.01). 
However, there was the same tendency as observed for TL. On post-
exposure Day 3, increased DNA strand break levels were observed 
for the two lower doses of NRCWE-002 when assessed as TL and 
for the lowest dose when assessed as %DNA. DNA strand break 
levels expressed as both TL and %DNA were increased for all 
NP-exposed mice 28  days post-exposure for all doses, compared 
with the vehicle controls (P  <  0.001). Pearson’s correlation coef-
ficient between %TDNA and TL in lung cells including all tested 
samples was R2 = 0.76 (results not shown).
The DNA strand break levels in BAL cells were lowered after 
exposure to NRCWE-002 1  day post-exposure (TL; P  <  0.001; 
Table  3). Three days post-exposure, NRCWE-001 statistically sig-
nificantly increased the level of TL for low and middle doses and 
NRCWE-002 exposure led to increased DNA strand break lev-
els at the highest dose compared with the vehicle controls (1.3-
fold; P < 0.001). Pearson’s correlation coefficient between TL and 
%TDNA in BAL cells was R2 = 0.47 (data not shown).
The DNA strand break levels in liver cells were statistically signif-
icantly increased 1 day after exposure to NRCWE-002 expressed as 
%DNA (Table 3). Increased DNA strand break levels were observed 
for the highest dose of NRCWE-001 3 days post-exposure and for 
lowest and the highest dose of NRCWE-001 28 days post-exposure. 
Pearson’s correlation coefficient between %TDNA and TL in liver 
cells was R2 = 0.62.
There was statistically significant difference between the geno-
toxic response in liver at the Day 1 (P < 0.01) and overall in BAL 
cells (P < 0.05) after i.t. exposure to NRCWE-001 and NRCWE-
002. There was no statistically significant difference between the 
genotoxic responses to NRCWE-001 and NRCWE-002 in lung 
tissue.
Total protein in BALF
Protein content in BALF was assessed as a marker of increased 
membrane permeability due to cell damage (Figure 3). The highest 
dose of NRCWE-001 significantly increased the protein concentra-
tion in BALF (P < 0.05) at all three post-exposure days. The protein 
concentration in BALF was unaffected by NRCWE-002 exposure. 
Overall, there was no statistically significant difference between the 
two studied NPs.
Table 1. Size distributions measure by dynamic light scattering for 
NRCWE-001 and NRCWE-002
NM NRCWE-001 NRCWE-002
Dose 18 54 162 18 54 162
Z-Average 
(d.nm)
107 107 108 1718 1977 1898
Pd 0.14 0.14 0.15 0.36 0.32 0.16
Hydrodynamic 
peak size
50.8 21 and 
58.5
68.1 1281 1484 1718
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Figure 1. Dynamic light scattering analysis of NRCWE-001 (top panel) and NRCWE-002 (bottom panel) in instillation medium (Nanopure water).
Table 2. Total cell counts from BALF and cells distribution by cells type 1, 3 and 28 days post-exposure to NRCWE 001, NRCWE 002 and 
vehicle (particle exposed groups n = 8, vehicle group n = 12)
Vehicle NRCWE 001 NRCWE 002
0 µg 18 µg 54 µg 162 µg 18 µg 54 µg 162 µg
Day 1
 Group 1 2 3 4 5 6 7
 Neutrophils 6.3 ± 1.8 13.2 ± 2.5 90.1 ± 5.4** 183.7 ± 20.6*** 9.7 ± 2.2 90.4 ± 15.4** 118.2 ± 9.6***
 Macrophages 54.9 ± 3.5 53.2 ± 5.3 54.6 ± 4.7 36.3 ± 4.3* 83.6 ± 6.7 36.8 ± 3.9 50.5 ± 6.7
 Eosinophils 1.7 ± 1.0 0.1 ± 0.1* 5.7 ± 1.7 1.5 ± 0.6 0.3 ± 0.2 3.3 ± 1.4 4.6 ± 1.9*
 Lymphocytes 0.8 ± 0.5 0.2 ± 0.1 0.5 ± 0.2 0.0 ± 0.0 0.3 ± 0.2 0.2 ± 0.1 0.1 ± 0.2
 Epithelial 18.8 ± 2.4 12.0 ± 1.8 10.3 ± 0.6* 6.7 ± 1.2** 24.0 ± 3.9 12.4 ± 2.6 10.6 ± 1.2
 Total BAL cells 70.0 ± 9.6 78.9 ± 8.7 161.3 ± 9.8*** 228.1 ± 23.1*** 117.8 ± 8.9 143.0 ± 14.8** 184.0 ± 13.9***
Day 3 9 10 11 12 13 14 15
 Neutrophils 0.4 ± 0.1 3.2 ± 1.9 19.4 ± 4.7*** 92.6 ± 15.3*** 2.2 ± 0.9 28.0 ± 8.5*** 78.3 ± 11.8***
 Macrophages 55.5 ± 8.9 60.5 ± 11.7 70.2 ± 7.8 93.6 ± 15.2 66.9 ± 7.9 92.8 ± 13.5 90.6 ± 12.5
 Eosinophils 0.3 ± 0.1 0.6 ± 0.4 6.2 ± 2.0 10.0 ± 3.1*** 0.9 ± 0.4 7.1 ± 4.7*** 10.2 ± 2.9***
 Lymphocytes 0.3 ± 0.1 0.0 ± 0.0 0.6 ± 0.3 6.0 ± 1.6 0.9 ± 0.3 1.9 ± 1.1 2.9 ± 1.1*
 Epithelial 13.9 ± 2.8 10.6 ± 1.8 12.4 ± 3.3 12.8 ± 2.0* 16.2 ± 3.2 15.6 ± 1.9 21.0 ± 4.2
 Total BAL cells 70.4 ± 11.1 74.9 ± 14.9 108.8 ± 13.1 215.0 ± 12.6*** 87.1 ± 9.1 145.5 ± 21.2** 203.1 ± 23.2***
Day 28 17 18 19 20 21 22 23
 Neutrophils 0.5 ± 0.2 1.2 ± 0.5 2.2 ± 0.7 9.9 ± 2.0*** 0.4 ± 0.4 5.4 ± 1.9** 8.3 ± 3.7**
 Macrophages 58.3 ± 7.9 87.1 ± 12.4 94.9 ± 15.6 121.8 ± 22.4* 48.7 ± 9.4 62.9 ± 4.5 61.3 ± 10.3
 Eosinophils 1.1 ± 1.0 1.4 ± 1.3 1.1 ± 0.9 0.2 ± 0.2 0.1 ± 0.1 1.4 ± 0.7 0.6 ± 0.5
 Lymphocytes 0.5 ± 0.3 1.6 ± 0.6 1.0 ± 0.6 2.9 ± 1.7 0.1 ± 0.1 4.0 ± 1.0*** 4.0 ± 1.8***
 Epithelial 11.1 ± 2.0 9.9 ± 0.9 11.2 ± 2.0 17.9 ± 3.7 13.5 ± 3.9 12.7 ± 1.6 16.1 ± 2.6
 Total BAL cells 71.4 ± 8.6 101.2 ± 12.5 110.3 ± 16.5 152.7 ± 24.1** 71.8 ± 10.2 86.2 ± 4.7 90.4 ± 15.7
Mean ± SEM (×103), *P < 0.05, **P < 0.01, ***P < 0.001 cells influx in diesel exhaust particle-treated group vs. vehicle controls, respectively.
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Figure 2. Levels of DNA strand breaks in lung tissue from mice 1, 3 and 28 days after intratracheal instillation of NRCWE-001 and NRCWE-002. Levels of DNA 
strand breaks was measured by comet assay: (A) data shown as tail length (TL) and (B) data shown as %DNA in tail (%TDNA). The values represent single 
mouse measurement in three different post-exposure times (1, 3 and 28 days) after single administration of NRCWE-001 and NRCWE-002 (18, 54, 162 µg/animal) 
and vehicle controls. The values represent mean of all animals in the group ± SEM (n = 8–12). *P ˂ 0.05, **P ˂ 0.01, ***P ˂ 0.001: TL and %TDNA, respectively, in 
NRCWE-001 and NRCWE-002–treated group vs. vehicle controls.
Table 3. Summary of comet assay results from BAL cells, lung and liver tissue 1, 3 and 28 days post-exposure to vehicle, NRCWE-001 and 
NRCWE-002 (vehicle group n = 12, particle-exposed groups n = 8)
Vehicle NRCWE-001 NRCWE-002
Dose 0 µg 18 µg 54 µg 162 µg 18 µg 54 µg 162 µg
1 day
BAL TL 14.3 ± 0.6 12.7 ± 0.7 14.3 ± 0.5 14.1 ± 0.5 10.0 ± 0.5*** 9.7 ± 0.5*** 9.4 ± 0.5***
BAL %TDNA 4.6 ± 0.4 4.2 ± 0.3 3.9 ± 0.3 3.7 ± 0.3 3.9 ± 0.6 4.2 ± 0.4 4.0 ± 0.4
Lung TL 9.9 ± 0.4 13.2 ± 1.1** 13.5 ± 0.8** 13.1 ± 0.4** 13.7 ± 0.4*** 17.9 ± 0.5*** 16.2 ± 0.7***
Lung %TDNA 3.8 ± 0.3 4.5 ± 1.0 4.4 ± 0.5 3.6 ± 0.3 3.2 ± 0.3 5.6 ± 0.4** 4.9 ± 0.5
Liver TL 16.3 ± 1.4 18.2 ± 0.5 14.7 ± 0.5 15.2 ± 0.8 19.3 ± 1.8 20.2 ± 1.5 20.3 ± 1.8
Liver %TDNA 4.5 ± 0.5 4.3 ± 0.3 4.1 ± 0.2 4.1 ± 0.4 6.6 ± 1.0* 7.0 ± 0.7* 6.2 ± 0.8*
3 days
BAL TL 12.7 ± 0.7 16.1 ± 0.4*** 16.6 ± 0.5*** 14.2 ± 0.3 9.2 ± 0.2* 15.8 ± 1.1 16.1 ± 1.1*
BAL % TDNA 5.1 ± 0.4 5.9 ± 0.7 6.2 ± 0.4 5.2 ± 0.3 4.4 ± 0.4 6.2 ± 0.5 7.4 ± 0.7*
Lung TL 10.7 ± 0.6 12.3 ± 0.4 12.0 ± 0.4 12.2 ± 0.5 13.2 ± 0.7** 12.9 ± 0.2* 12.3 ± 0.5
Lung %TDNA 2.1 ± 0.4 3.3 ± 1.3 2.7 ± 0.2 2.8 ± 0.3 3.7 ± 1.8** 3.2 ± 0.2 3.1 ± 0.3
Liver TL 18.2 ± 1.4 15.3 ± 1.1 14.1 ± 0.6 21.8 ± 0.9 21.0 ± 2.1 18.8 ± 0.4 18.7 ± 0.7
Liver %TDNA 4.5 ± 0.5 3.6 ± 0.4 4.0 ± 0.3 7.2 ± 0.5** 6.9 ± 1.1 5.7 ± 0.3 5.8 ± 0.4
28 days
BAL TL 13.9 ± 0.7 14.3 ± 0.7 12.8 ± 0.8 12.4 ± 0.3 15.1 ± 1.1 15.3 ± 1.2 13.7 ± 0.9
BAL %TDNA 4.8 ± 0.5 5.2 ± 0.6 4.1 ± 0.5 4.2 ± 0.4 6.4 ± 0.8 5.1 ± 0.7 4.6 ± 0.5
Lung TL 9.1 ± 0.4 16.1 ± 0.9*** 17.0 ± 0.9*** 15.4 ± 0.8*** 16.0 ± 0.5*** 15.4 ± 0.5*** 15.3 ± 1.3***
Lung %TDNA 2.0 ± 0.4 5.0 ± 0.7** 6.5 ± 0.7*** 5.7 ± 0.5*** 5.0 ± 0.3** 5.2 ± 0.4** 5.9 ± 1.0***
Liver TL 18.4 ± 1.1 23.1 ± 1.2** 21.4 ± 0.5 24.3 ± 0.9** 18.5 ± 0.5 19.7 ± 0.8 17.9 ± 1.0
Liver %TDNA 5.7 ± 0.6 9.3 ± 1.1** 5.8 ± 0.4 7.7 ± 0.6 5.6 ± 0.4 6.2 ± 0.6 6.0 ± 0.6
Mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001: using non-parametric two-way ANOVA with post hoc Tukey-type multiple comparison test with time after 
exposure and dose as categorical variables.
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Saa mRNA expression
Pulmonary Saa3 mRNA levels were used as a biomarker of pulmo-
nary acute phase response (23,24), and hepatic Saa1 mRNA levels 
were used as biomarker of hepatic acute phase response (25,37).
Pulmonary Saa3 mRNA expression levels were statistically sig-
nificantly increased at all three time points following instillation of 
162 µg NCRWE 001 and -002 NPs (P < 0.001; Figure 4). The expres-
sion levels of Saa3 mRNA were highest at Day 1. At 1 and 28 days 
post-exposure, Saa3 mRNA expression levels were also increased 
for the middle dose of NRCWE-002 (P  <  0.001). No other time 
or dose-related changes in pulmonary Saa3 expression levels were 
observed. There was a strong correlation between specific surface 
area (BET) and level of pulmonary Saa3 mRNA expression 1 day 
post-exposure (NRCWE-001 R2 = 0.57 and NRCWE-002 R2 = 0.75; 
results not shown). Pulmonary Saa3 mRNA levels dose dependently 
increased, and we did not observe any statistically significant differ-
ences between the two studied NPs.
Hepatic Saa1 mRNA levels increased in a dose-dependent man-
ner 24 h after exposure for both TiO2 NPs, and only the highest dose 
was statistically significantly increased compared with the vehicle 
control (Figure 5). After 3 days, hepatic Saa1 levels were statistically 
significantly increased for the two highest doses of NRCWE-001 but 
not for NRCWE-002. No effects were observed at Day 28. There was 
no statistically significant difference between the two studied NPs.
Discussion
It has been discussed whether the surface charge of NMs is critical 
for the biological interactions of NMs (38,39). It has been suggested 
that positively charged NMs bind to cell surfaces and are taken up by 
cells more efficiently (40–42). We investigated the inflammatory and 
genotoxic response of two TiO2 NPs at 3 doses (18, 54 or 162 µg/
mouse) and 3 time points (1, 3 and 28 days post-exposure) following 
i.t. NRCWE-002 was surface modified exposing amino groups and 
consequently has a positive zeta potential, whereas NRCWE-001was 
used as delivered from the supplier. NRCWE-001 is an unmodified 
rutile TiO2 and has a negative zeta potential at physiological pH, 
reflecting an overall negative surface charge presumably caused by 
the polarity in the crystal structure of the metal oxide. The NRCWE-
002 has been reported to induce more DNA damage than NRCWE-
001 in HK-2 human kidney cells in vitro (43). The two TiO2 NPs 
were equally cytotoxic and marginally damaged the hepatoblastoma 
C3A cell line in humans (33,34). In a recent study, the global gene 
expression in mouse lung was very similar for NRCWE-001 and 
-002 (3). In general, the pulmonary transcriptional responses to the 
two TiO2s were more similar to each other than to other TiO2 NPs 
and TiO2-containing paint dusts (3).
In this study, inflammation, determined as the influx of neutro-
phils, was time- and dose dependent and persisted at the highest 
instilled doses 28 days post-exposure for both NPs. We detected no 
statistically significant differences in BAL cell numbers for the two 
TiO2 NPs. Similarly, pulmonary cellular damage as determined by 
increased protein concentration in BALF was not statistically differ-
ent for NRCWE-001 and NRCWE-002.
The TiO2 NPs are likely to be cleared slowly from lung and to 
translocate and accumulate slowly (<1% of the instilled dose) in 
the liver during the 28  days as we have reported previously with 
another TiO2 NP (10,11). Both NRCWE-001 and -002 induced 
increased DNA strand break levels across time points, doses and tis-
sues. BothTiO2 NPs induced increased DNA strand break levels in 
lung tissue at all doses 1 and 28 days post-exposure, and NRCWE-
002 also increased DNA strand break levels at the low and middle 
Figure 3. Total protein concentration in BALF with dose response effect in mice 1, 3 and 28 days after intratracheal (i.t.) instillation of NRCWE-001 and NRCWE-
002. Female mice were treated by a single dose i.t. of NRCWE-001, NRCWE-002 in three different concentrations (18, 54, 162 µg/mouse), or vehicle, and the mice 
were killed 1, 3 and 28 days post-exposure. The values represent mean of all animals in the group ± SEM (n = 8–12). *P ˂ 0.05: protein concentration in NRCWE-
001 and NRCWE-002–treated group vs. vehicle controls.
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dose 3  days post-exposure. Importantly, there was no statistically 
significant difference between genotoxicity in lung tissue for the 
two TiO2 NPs. The DNA strand break levels were statistically sig-
nificantly different for NRCWE-001 and -002 for liver and BAL 
cells, but no consistent pattern was observed. The statistically sig-
nificant difference between NRCWE-001 and NRCWE-002-induced 
BAL cell genotoxicity was likely driven by the lowered DNA 
strand break levels observed for NRCWE-002. However, NRCWE-
002 also induced increased DNA strand break levels in BAL cells 
(at the highest dose on Day 3 post-exposure). There is no plausi-
ble biological explanation for the variation between the materials 
and over time, and therefore, we believe this is a chance finding. In 
liver, NRCWE-002 increased DNA strand break levels on Day 1, 
whereas NRCWE-001 increased DNA strand break levels on Day 
3 and Day 28 post-exposure. We doubt that there is any biological 
explanation for the observed differences in the hepatic NRCWE-001 
and NRCWE-002-induced increased levels of DNA strand breaks 
across doses and time points, and we consider this a chance finding. 
However, we only assessed DNA damage as DNA strand breaks in 
the comet assay, and it is possible that the genotoxic potential for 
NRCWE-001 and -002 may differ for other types of DNA damage.
The variation in DNA strand break levels over time indicates that 
the level of strand breaks was greater on Day 1 and Day 28 than on 
Day 3. Actually, we have previously made similar observations fol-
lowing i.t. of carbon black NPs (15,30), diesel exhaust particles (31) 
and, to a lesser extent, carbon nanotubes.(44) We have no biological 
explanation for this, but we have observed similar time-dependent 
variation in the global pulmonary transcription pattern following 
Figure 4. Pulmonary Saa3 mRNA expression levels with dose response effect in mice 1, 3 and 28 days after intratracheal instillation of NRCWE-001 and NRCWE-
002. Saa3 mRNA levels were normalized to 18S RNA. The values represent mean of all animals in group ± SEM (n = 8–12). ***P ˂ 0.001: Saa3 mRNA expression 
level in TiO2 NP-treated group vs. vehicle controls.
Figure 5. Hepatic Saa1 mRNA expression levels with dose response effect in mice 1, 3 and 28 days after intratracheal instillation of NRCWE-001 and NRCWE-002. 
Saa1 mRNA levels were normalized to 18S RNA. The values represent mean of all animals in group ± SEM (n = 8–12). *P ˂ 0.05, **P < 0.01,  ***P ˂ 0.001: Saa1 
mRNA expression level in TiO2 NP-treated group vs. vehicle controls.
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i.t. of carbon black NPs (10). It is therefore possible that the time-
dependent variation in DNA strand break levels may reflect a true 
biological effect.
Acute phase response is a risk factor for cardiovascular disease 
(24,45). We have previously shown that pulmonary deposition of 
NMs leads to dose-dependent induction of pulmonary acute phase 
response (23,24,26). Serum amyloid (SAA) binds to high-density 
cholesterol (HDL), and with marked increases, SAA displaces Apo 
A-I in HDL and becomes the major HDL protein (24,46). HDL-
containing SAA is impaired in its ability carry out cholesterol efflux 
from macrophages. It has been demonstrated that SAA promotes 
plaque progression in atherosclerosis-prone apolipoprotein E 
knockout mice (46), and we recently found that i.t. of SAA is capa-
ble of doing so as well (Daniel Vest Christophersen et al., unpub-
lished). Pulmonary Saa3 transcription is used as a biomarker of 
pulmonary acute phase response (24), whereas hepatic Saa1 tran-
scription is a biomarker of hepatic acute phase response (47), and 
induction of acute phase response is used as a biomarker of particle-
induced cardiovascular risk (23–25). In the present study, both TiO2 
NPs induced a strong acute phase gene expression in the lung 1 day 
after exposure and increased Saa3 expression was observed even 
after 28 days. Induction of a systemic acute phase response in the 
liver was observed in terms of increased expression of Saa1, the 
hepatic isoform of Saa. However, the hepatic acute phase response 
was weaker in terms of fold increase and had much shorter dura-
tion compared with the pulmonary acute phase response. Thus, at 
Day 1, the pulmonary Saa3 expression was increased 106-fold for 
NRCWE-001 and 64-fold for NRCWE-002, respectively, whereas 
the corresponding hepatic Saa1 expression was increased 28-fold 
for NRCWE-001 and increased 9-fold for NRCWE-002, respec-
tively. We have previously reported strong time- and dose-dependent 
pulmonary acute phase response that correlate with total deposited 
surface area of TiO2 and carbon black NPs and with neutrophil 
influx in BALF (23,24). Interestingly, an accompanying hepatic 
acute phase response was observed following i.t. to two different 
carbon nanotubes (25) and to a much lesser extent after exposure 
to another TiO2 NPs (10) and even less after pulmonary exposure 
to carbon black NPs (28). Taken together, our results may support 
the notion that pulmonary and systemic acute phase responses con-
stitute a signalling pathway between particle-induced lung inflam-
mation and cardiovascular health effects (24).
We have previously assessed TiO2 NPs and sanding dust from 
paint with and without nanoparticles using the same experimental 
set-up (1–3,10,11,17,48). Pulmonary exposure to TiO2 NPs and 
sanding dust induced pulmonary inflammation but no genotoxicity 
(1). In a screening of sanding dust from different paints with and 
without NPs, DNA strand break levels were found to depend on 
the paint matrix rather than on the content of NPs (17). It has been 
proposed that genotoxicity of TiO2 may be due to the reactivity of 
the surface and it producing reactive oxygen species per se or by 
biochemical and inflammatory cellular responses (49). It seems that 
substantial change of surface of TiO2, which includes change from 
negative to positive charge, did not change the biological effects 
in mouse lung. It is therefore unlikely that reactive oxygen species 
generation at the TiO2 surface is responsible for genotoxicity and 
inflammation but rather cellular responses are important.
The inflammatory response to the TiO2 NP exposure in terms of 
neutrophil influx at Day 1(184 000 and 118 000 for NRCWE-001 
and 002, respectively) was very similar to the previously reported 
response to the same dose of a surface-coated TiO2 NP [UV-Titan 
L181 (189 000 neutrophils) (1), Printex90 (129 000 neutrophils) 
and the diesel exhaust particle NIST1650b (121 000 neutrophils)] 
using the same experimental set-up (31). At Day 28, significant neu-
trophil influx was observed for both TiO2 NPs and carbon black 
NPs, whereas no neutrophil influx was observed for diesel exhaust 
particles. There were no statistically significant differences in the 
BAL cell composition between NRCWE-001 and NRCWE-002. 
These results are in agreement with previously observed inflamma-
tion in lung after i.t. and inhalation in mice and rats (21,50–52).
Overall, of the change or the surface charge, the studied rutile 
TiO2 NP did not influence the toxicological response following pul-
monary exposure and therefore, at least with this material, change of 
surface charge did not affect the toxicity of the NM.
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